Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) currently has a daily average trading volume of 276.88K but it saw 358087739 shares traded in last market. With a market cap of 24.22M USD, the company’s current market price of $0.76 came rising about 97.87 while comparing to the previous closing price of $0.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.28 and as low as $0.26.
Taking a look at 20-day trading activity of Redhill Biopharma Ltd. ADR (RDHL) gives us an average price of $0.3962, while its current price level is -76.83% below from 52-week high level whereas it is 195.72% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4088 while that of 200 days or SMA-200 reads an average of $0.6406. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.05% during that period while stretching the period over a month that decreases to 8.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 86.49 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which initiated the stock as “Overweight” in its note to investors issued on August 31, 2021, recommending a price target of $22 for it.
Over the week, RDHL’s stock price is moving 100.00% up while it is 109.94% when we observe its performance for the past one month. Year-to-date it is -47.95% down and over the past year, the stock is showing a downside performance of -39.20%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.3 beaten by the consensus estimate of -0.23 for the same.
Currently, Redhill Biopharma Ltd. ADR’s total number of outstanding shares is 31.87M. Company’s return on investment (ROI) stands at 255.09%. Stock’s beta reads 3.63. Stock has a price to book (P/B) ratio of 0.86 while price to sale or P/S ratio amounts to 0.68. Its return on asset (ROA) is 11.22% on average.
